Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice

American Journal of Cardiology

Volumn 87, Issue 6, 2001, Pages 782-785

  Wienbergen, Harm ^a,g   Schiele, Rudolf ^a   Gitt, Anselm K ^a   Schneider, Steffen ^a   Heer, Tobias ^a   Gottwik, Martin ^b   Gieseler, Ulf ^c   Weber, Michael A ^d   Müller, Claus Heinrich ^e   Neubaur, Jürgen ^f   Senges, Jochen ^a  

^a Herzzentrum Ludwigsafen   (Germany)

^b KLINIKUM NÜRNBERG   (Germany)

^c Diakonissen Stiftungs Krankenhaus   (Germany)

^d Kreisklinik ^*  (Germany)

^e Municipal Hospital of Lueneburg   (Germany)

^f Städtisches Krankenhaus   (Germany)

^g Medizinische Klinik C   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL PRACTICE; COMORBIDITY; FEMALE; HEART CATHETERIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE;

AGED; CEREBROVASCULAR ACCIDENT; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 0035869165     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01505-8     Document Type: Article

References (12)

1. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
2. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
3. A randomised comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected acute myocardial infarction
4. Incidence of vascular stroke in patients with acute myocardial infarction receiving fibrinolytic treatment
5. Cerebrovascular events after myocardial infarction: Analysis of the GISSI trial
6. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment
7. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction
8. Intracerebral hemorrhage, cerebral infarction and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study
9. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
10. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practice
11. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
12. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis